StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by Barrheadon Mar 22, 2019 2:34pm

110 Views

Post# 29524434

RE:Big support

Most of the High Activity trading is in the red today, so I don't believe the demand for this stock is totally burnt out, but just general market condtions are dicating where this will end up today or even a week from now.

Symbol	Price	Change	Volume
ACB	12.16	-0.62	17,543,422
BBD.B	2.73	-0.09	8,220,864
ECA	9.53	-0.32	5,871,640
ZEB	28.56	-0.31	4,901,701
CPG	4.49	-0.17	4,746,402
G	14.40	-0.54	4,213,072
TGOD	4.86	-0.16	4,091,824
XFN	37.32	-0.40	3,768,649
HEXO	8.64	-0.40	3,182,488
BTE	2.38	-0.12	3,073,023